A collaborative effort to evaluate treatment of liver and pancreatic tumors

HOUSTON, DENVER and CHICAGO ? The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences today announced a strategic research collaboration to evaluate the treatment of tumors of the pancreas and liver by integrating interventional delivery of SD-101, an investigational toll-like receptor 9 (TLR9) agonist, in combination with checkpoint inhibition immunotherapy. Under the agreement, MD Anderson and TriSalus […]

Read more

Study offers localized treatment direction for a cause of Crohn's disease

People with Crohn's disease are typically treated with powerful anti-inflammatory medications that act throughout their body, not just in their digestive tract, creating the potential for unintended, and often serious, side effects. New research from the lab of Mark Sundrud, PhD, at Scripps Research, Florida suggests a more targeted treatment approach is possible. Crohn's disease develops from chronic inflammation in […]

Read more

A new technology to see tubes in 3-D in mice shows how the liver can recover in Alagille syndrome

Many diseases affect different vessels in our body, such as blood vessels, bile ducts or airways. Visualizing these in animal models of disease, to better understand what is actually going wrong form a structural point of view has been an area of intense research. We developed a new method, independent of antibodies or microscopes, to visualize multiple vessels at the […]

Read more

Algorithm Uses Routine Blood Tests to Detect Advanced Liver Disease

NEW YORK (Reuters Health) – It may be possible to pick up occult liver cirrhosis with an algorithm that uses data from routine blood tests, according to new research. The CIRRUS algorithm can find “a fingerprint for cirrhosis in the common blood tests done routinely by GPs,” Dr. Nick Sheron of the Foundation for Liver Research said in a news […]

Read more

Cytoglobin: Key player in preventing liver disease

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice. CYGB, discovered in 2001 by Professor Norifumi Kawada, is present in hepatic stellate cells, the cells that produce fibrotic molecules such as collagens when the liver has acute or chronic inflammation induced by different etiologies. The enhancement of CYGB on […]

Read more

Kruppel-like factor 15 controls skeletal muscle fat uptake and utilization

Metabolic diseases, such as obesity and type 2 diabetes, have risen to epidemic proportions in the U.S. and occur in about 30 percent of the population. Skeletal muscle plays a prominent role in controlling the body's glucose levels, which is important for the development of metabolic diseases like diabetes. In a recent study, published in The Journal of Clinical Investigation, […]

Read more

Liver cancer ‘signature’ in gut holds clues to cancer risk

People with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk, a UNSW Sydney study has found. The distinctive gut microbiome profile of a person with liver cancer linked to non-alcoholic fatty liver disease (NAFLD) could be the key to predicting someone’s risk of developing the cancer, say researchers from the UNSW Microbiome Research […]

Read more

Terry White Chemists Clomipramine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS CLOMIPRAMINE Contains the active ingredient, clomipramine (as clomipramine hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about clomipramine. It does not contain all the available information.It does not take […]

Read more

Steglatro

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. STEGLATRO┬« This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems. Ertugliflozin pyroglutamic acid Consumer Medicine Information What is in […]

Read more
1 2 3 7